| Literature DB >> 32819183 |
Ricard Cervera1, Ignasi Rodríguez-Pintó2, Kim Legault3, Doruk Erkan4.
Abstract
The Task Force on Catastrophic Antiphospholipid Syndrome (CAPS) met again on occasion of the 16th International Congress on Antiphospholipid Antibodies (aPL) that was held in Manchester, England, in September 2019. Its aims were to assess the up-to-date knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, precipitating factors, and treatment of CAPS. This article summarizes the main aspects that were presented during the Task Force meeting at that Congress.Entities:
Keywords: Anticardiolipin antibodies; antiphospholipid syndrome; catastrophic antiphospholipid syndrome
Mesh:
Substances:
Year: 2020 PMID: 32819183 DOI: 10.1177/0961203320951260
Source DB: PubMed Journal: Lupus ISSN: 0961-2033 Impact factor: 2.911